Cardinal Health entered into an underwriting agreement for the sale of $2.9 billion aggregate principal amount of senior unsecured notes. This financing move is intended to support the company's recently announced strategic acquisitions.
The debt offering includes $500 million of 4.700% Notes due 2026, $750 million of 5.000% Notes due 2029, $1.0 billion of 5.350% Notes due 2034, and $650 million of 5.750% Notes due 2054.
This capital raise provides Cardinal Health with the necessary financial flexibility to complete its acquisitions of a majority stake in GI Alliance and the Advanced Diabetes Supply Group, reinforcing its strategy to expand in specialty and at-Home Solutions markets.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.